Abstract 5440: Deep-learning model for tumor type classification enables enhanced clinical decision support in cancer diagnosis

Madison Darmofal(Memorial Sloan Kettering Cancer Center), Michael Berger(Memorial Sloan Kettering Cancer Center), Anoop Balakrishnan Rema(Memorial Sloan Kettering Cancer Center), Anna M. Varghese(Memorial Sloan Kettering Cancer Center), Quaid Morris(Kettering University), Jason C. Chang(Memorial Sloan Kettering Cancer Center), Jie‐Fu Chen(Memorial Sloan Kettering Cancer Center), Aijazuddin Syed(Memorial Sloan Kettering Cancer Center), Gurnit Atwal(Ontario Institute for Cancer Research), Shalabh Suman(Memorial Sloan Kettering Cancer Center)
Cancer Research
April 4, 2023
10.1158/1538-7445.am2023-5440
Cited by 2

Related Papers

GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function
|Genome biology|2008|1.1k
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
|Cell stem cell|2017|851
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
|Nature Genetics|2020|739
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making
|JCO Precision Oncology|2017|529
First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study
|Cancer Discovery|2017|418